Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | |||
---|---|---|---|---|---|---|
Aktuell sind keine Nachrichten verfügbar, die den gewählten Kriterien entsprechen. |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
DIGICANN VENTURES | 0,011 | 0,00 % | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 26.01.2024 | The following instruments on XETRA do have their first trading 26.01.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 26.01.2024
Aktien
1 KYG7006A1094 Perfect Corp.
2 JP3501950004... ► Artikel lesen | |
SANOCHEMIA PHARMAZEUTIKA | - | - | Nachlese: Magnus Brunner vs. FMA" EOSS holt nach Sanochemia auch BDI BioEnergy; Bettina Pfluger (Christian Drastil) | Um 12:12 liegt der ATX mit +0.03 Prozent im Plus bei 3452 Punkten (Ultimo 2023: 3435, 0.49% ytd). Topperformer der PIR-Group sind Addiko Bank mit +1.82% auf 15.425 Euro, dahinter DO&CO mit +1.79% auf... ► Artikel lesen | |
WPD PHARMACEUTICALS | 0,027 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 23.04.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 23.04.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 23.04.2024ISIN NameAU000000AC89 AUSCANN... ► Artikel lesen | |
IONIS PHARMACEUTICALS | 37,420 | -1,73 % | Ionis Pharmaceuticals, Inc.: Ionis reports first quarter 2024 financial results | WAINUATM launch on track; EU and Canada approval decisions expected this year
Olezarsen NDA submitted to FDA for FCS; preparing EU regulatory submission
Positive Phase 3 donidalorsen data for HAE;... ► Artikel lesen | |
SINOPHARM | 2,408 | -1,35 % | G Sachs Slightly Cuts SINOPHARM TP to $21.17; 1Q Results Weak | ||
INDIVA | 0,022 | 0,00 % | Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income From Operations | LONDON, Ontario--(BUSINESS WIRE)--Indiva Limited (the "Company" or "Indiva") (TSXV:NDVA), the leading Canadian producer of cannabis edibles, is pleased to announce its financial and operating results... ► Artikel lesen | |
CSPC PHARMA | 0,810 | +2,61 % | CSPC PHARMA (01093): NEXT DAY DISCLOSURE RETURN | ||
ORAMED PHARMACEUTICALS | 2,244 | +0,36 % | ORAMED PHARMACEUTICALS INC. - 8-K, Current Report | ||
ADASTRA | 0,089 | -3,26 % | Adastra Holdings Ltd.: Adastra Announces Intention to Terminate SEC Reporting Obligations | LANGLEY, BC / ACCESSWIRE / May 1, 2024 / Adastra Holdings Ltd. (CSE:XTRX)(FRA:D2EP) ("Adastra" or the "Company"), a leading cannabis processor and producer of two top Canadian concentrates brands, with... ► Artikel lesen | |
SELLAS LIFE SCIENCES | 1,190 | -3,57 % | SELLAS Life Sciences Group, Inc.: SELLAS Announces Positive Phase 2 Preliminary Data of SLS009 in r/r AML Achieving a 100% Response Rate in Patients with ASXL1 Mutation At the Optimal Dose Level | - The Company Filed IP Protection Related to the ASXL1 Mutation, a Highly Prevalent Gene Mutation in Myeloid Malignancies and Solid Tumors With Significant Market Potential - - 100% Overall Response... ► Artikel lesen | |
ACADIA PHARMACEUTICALS | 15,890 | -0,94 % | ACADIA Pharmaceuticals Inc expected to post earnings of 5 cents a share - Earnings Preview | ||
MADRIGAL PHARMACEUTICALS | 189,00 | -6,57 % | 'Remarkable interest': Madrigal touts early launch progress for first MASH drug Rezdiffra despite VA hurdle | ||
NUMINUS WELLNESS | 0,054 | +1,90 % | Numinus Wellness Inc: Numinus to close clinics, work with Field Trip Health | ||
CATALYST PHARMACEUTICALS | 13,905 | -1,24 % | Santhera Pharmaceuticals Holding AG: Santhera's Partner Catalyst Pharmaceuticals lanciert AGAMREE® (Vamorolon) in den Vereinigten Staaten | AGAMREE® ist von der U.S. FDA zugelassen und jetzt in den USA für die Behandlung von Duchenne-Muskeldystrophie (DMD) bei Patienten ab 2 Jahren erhältlichDies folgt auf die erste kommerzielle Einführung... ► Artikel lesen | |
MOLECULE HOLDINGS | 0,001 | 0,00 % | Molecule Holdings Inc: Molecule Holdings receives partial revocation of CTO |